The Nordic region is a potentially lucrative area for medical device companies to expand into, with analyst research estimating Sweden alone to have a 2.7% …

Prescription drug insurance in Canada is provided by a mixture of government and private plans. Government plans offer coverage to about a quarter of the …

Late last year, visionaries from Merck, Syneos Health and Accenture took part in a live video debate on what now influences the way life sciences …

Ben Wylie at ChargePoint Technology looks back on key learnings from 2021 for cleanroom pharmaceutical manufacturing. He explores why flexibility is key to overcoming sterile …

Across Asia, pharma leaders are working hard to accelerate their Industry 4.0 digital transformation and, in the process, ensure current Good Practice (cGXP) compliance. IDC …

In life sciences, research, advances in instrumentation, new types of measurements that are now possible and improved computational tools are generating not only significantly more …

Gastric cancer is the fifth most common cancer, with around one million annual incidences worldwide, and it represents the fourth most common cause of cancer …

Traditionally, most marketed drugs, irrespective of their route of delivery, have had relatively low molecular weights. Nowhere has this been more markedly true than in …

In recent years, a consensus has grown around the concern that clinical trials in the United States are neither adequately inclusive nor diverse. For example, …

Decentralised clinical trials (DCTs) have existed for years in different shapes and forms. Urged by the COVID-19 pandemic, restrictions to in-person patient visits and other …